138 related articles for article (PubMed ID: 1523534)
1. Self-treatment using a 0.5% podophyllotoxin cream of external genital condylomata acuminata in women. A placebo-controlled, double-blind study.
von Krogh G; Hellberg D
Sex Transm Dis; 1992; 19(3):170-4. PubMed ID: 1523534
[TBL] [Abstract][Full Text] [Related]
2. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of condylomata acuminata in women. A placebo-controlled, double-blind study.
Syed TA; Lundin S; Ahmad SA
Dermatology; 1994; 189(2):142-5. PubMed ID: 8075441
[TBL] [Abstract][Full Text] [Related]
3. A single-blind study of podophyllotoxin cream 0.5% and podophyllotoxin solution 0.5% in male patients with genital warts.
Petersen CS; Agner T; Ottevanger V; Larsen J; Ravnborg L
Genitourin Med; 1995 Dec; 71(6):391-2. PubMed ID: 8566980
[TBL] [Abstract][Full Text] [Related]
4. Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts.
Lacey CJ; Goodall RL; Tennvall GR; Maw R; Kinghorn GR; Fisk PG; Barton S; Byren I;
Sex Transm Infect; 2003 Aug; 79(4):270-5. PubMed ID: 12902571
[TBL] [Abstract][Full Text] [Related]
5. Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution.
Strand A; Brinkeborn RM; Siboulet A
Genitourin Med; 1995 Dec; 71(6):387-90. PubMed ID: 8566979
[TBL] [Abstract][Full Text] [Related]
6. Topical treatment of penile condylomata acuminata with podophyllotoxin 0.3% solution, 0.3% cream and 0.15% cream. A comparative open study.
Syed TA; Lundin S
Dermatology; 1993; 187(1):30-3. PubMed ID: 8324274
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte interferon-alpha versus podophyllotoxin in cream for the treatment of genital warts in males. A placebo-controlled, double-blind, comparative study.
Syed TA; Cheema KM; Khayyami M; Ahmad SA; Ahmad SH; Ahmad S; Ahmad SA
Dermatology; 1995; 191(2):129-32. PubMed ID: 8520059
[TBL] [Abstract][Full Text] [Related]
8. A multicentre, randomised, double-blind, placebo controlled study of cryotherapy versus cryotherapy and podophyllotoxin cream as treatment for external anogenital warts.
Gilson RJ; Ross J; Maw R; Rowen D; Sonnex C; Lacey CJ
Sex Transm Infect; 2009 Dec; 85(7):514-9. PubMed ID: 19700413
[TBL] [Abstract][Full Text] [Related]
9. Self-treatment using 0.25%-0.50% podophyllotoxin-ethanol solutions against penile condylomata acuminata: a placebo-controlled comparative study.
von Krogh G; Szpak E; Andersson M; Bergelin I
Genitourin Med; 1994 Apr; 70(2):105-9. PubMed ID: 8206467
[TBL] [Abstract][Full Text] [Related]
10. Management of genital warts in women with human leukocyte interferon-alpha vs. podophyllotoxin in cream: a placebo-controlled, double-blind, comparative study.
Syed TA; Khayyami M; Kriz D; Svanberg K; Kahlon RC; Ahmad SA; Ahmad SA
J Mol Med (Berl); 1995 May; 73(5):255-8. PubMed ID: 7670929
[TBL] [Abstract][Full Text] [Related]
11. Topical treatment of venereal warts: a comparative open study of podophyllotoxin cream versus solution.
Claesson U; Lassus A; Happonen H; Hogström L; Siboulet A
Int J STD AIDS; 1996 Oct; 7(6):429-34. PubMed ID: 8940672
[TBL] [Abstract][Full Text] [Related]
12. Self-treatment of female external genital warts with 0.5% podophyllotoxin cream (Condyline) vs weekly applications of 20% podophyllin solution.
Hellberg D; Svarrer T; Nilsson S; Valentin J
Int J STD AIDS; 1995; 6(4):257-61. PubMed ID: 7548288
[TBL] [Abstract][Full Text] [Related]
13. Patient-applied podofilox for treatment of genital warts.
Beutner KR; Conant MA; Friedman-Kien AE; Illeman M; Artman NN; Thisted RA; King DH
Lancet; 1989 Apr; 1(8642):831-4. PubMed ID: 2564912
[TBL] [Abstract][Full Text] [Related]
14. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. A placebo-controlled, double-blind study.
Syed TA; Lundin S; Ahmad M
Dermatology; 1994; 189(1):65-8. PubMed ID: 8003791
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized trial of 0.5% podofilox and placebo for the treatment of genital warts in women.
Greenberg MD; Rutledge LH; Reid R; Berman NR; Precop SL; Elswick RK
Obstet Gynecol; 1991 May; 77(5):735-9. PubMed ID: 2014088
[TBL] [Abstract][Full Text] [Related]
16. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
[TBL] [Abstract][Full Text] [Related]
17. An open, comparative, study of the efficacy of 0.5% podophyllotoxin lotion and 25% podophyllotoxin solution in the treatment of condylomata acuminata in males and females.
Kinghorn GR; McMillan A; Mulcahy F; Drake S; Lacey C; Bingham JS
Int J STD AIDS; 1993; 4(4):194-9. PubMed ID: 8399497
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary report of podophyllotoxin in the treatment of genital warts in China].
Wang H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Apr; 13(2):152-4. PubMed ID: 1831715
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of 0.5% podofilox solution in the treatment and suppression of anogenital warts.
Bonnez W; Elswick RK; Bailey-Farchione A; Hallahan D; Bell R; Isenberg R; Stoler MH; Reichman RC
Am J Med; 1994 May; 96(5):420-5. PubMed ID: 8192173
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of endoscopic therapy of anal canal condylomata acuminata with podophyllotoxin.
Tzathas C; Stavrianeas NG; Triantafyllou K; Triantafyllou G; Ladas SD
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):364-7. PubMed ID: 17309460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
